Table of Content

1 Pneumonia Vaccine Market Overview
1.1 Product Overview and Scope of Pneumonia Vaccine
1.2 Pneumonia Vaccine Segment by Type
1.2.1 Global Pneumonia Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Pneumococcal Conjugate Vaccine (PCV13)
1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.2.4 Other
1.3 Pneumonia Vaccine Segment by Application
1.3.1 Global Pneumonia Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Sepsis
1.4 Global Pneumonia Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumonia Vaccine Revenue 2016-2027
1.4.2 Global Pneumonia Vaccine Sales 2016-2027
1.4.3 Pneumonia Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pneumonia Vaccine Market Competition by Manufacturers
2.1 Global Pneumonia Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pneumonia Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pneumonia Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pneumonia Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Pneumonia Vaccine Market Competitive Situation and Trends
2.5.1 Pneumonia Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pneumonia Vaccine Players Market Share by Revenue
2.5.3 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pneumonia Vaccine Retrospective Market Scenario by Region
3.1 Global Pneumonia Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pneumonia Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pneumonia Vaccine Market Facts & Figures by Country
3.3.1 North America Pneumonia Vaccine Sales by Country
3.3.2 North America Pneumonia Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pneumonia Vaccine Market Facts & Figures by Country
3.4.1 Europe Pneumonia Vaccine Sales by Country
3.4.2 Europe Pneumonia Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pneumonia Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Pneumonia Vaccine Sales by Region
3.5.2 Asia Pacific Pneumonia Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pneumonia Vaccine Market Facts & Figures by Country
3.6.1 Latin America Pneumonia Vaccine Sales by Country
3.6.2 Latin America Pneumonia Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pneumonia Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Pneumonia Vaccine Sales by Country
3.7.2 Middle East and Africa Pneumonia Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pneumonia Vaccine Historic Market Analysis by Type
4.1 Global Pneumonia Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Pneumonia Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Pneumonia Vaccine Price by Type (2016-2021)

5 Global Pneumonia Vaccine Historic Market Analysis by Application
5.1 Global Pneumonia Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Pneumonia Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Pneumonia Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Inc. Pneumonia Vaccine Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Glaxosmithkline Plc.
6.2.1 Glaxosmithkline Plc. Corporation Information
6.2.2 Glaxosmithkline Plc. Description and Business Overview
6.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Product Portfolio
6.2.5 Glaxosmithkline Plc. Recent Developments/Updates
6.3 Merck & Co., Inc.
6.3.1 Merck & Co., Inc. Corporation Information
6.3.2 Merck & Co., Inc. Description and Business Overview
6.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck & Co., Inc. Pneumonia Vaccine Product Portfolio
6.3.5 Merck & Co., Inc. Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Corporation Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Pasteur Pneumonia Vaccine Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 Serum Institute of India Pvt. Ltd.
6.5.1 Serum Institute of India Pvt. Ltd. Corporation Information
6.5.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
6.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Portfolio
6.5.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Johnson & Johnson Pneumonia Vaccine Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Astellas Pharma Inc.
6.6.1 Astellas Pharma Inc. Corporation Information
6.6.2 Astellas Pharma Inc. Description and Business Overview
6.6.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Astellas Pharma Inc. Pneumonia Vaccine Product Portfolio
6.7.5 Astellas Pharma Inc. Recent Developments/Updates
6.8 Astrazeneca Plc.
6.8.1 Astrazeneca Plc. Corporation Information
6.8.2 Astrazeneca Plc. Description and Business Overview
6.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Astrazeneca Plc. Pneumonia Vaccine Product Portfolio
6.8.5 Astrazeneca Plc. Recent Developments/Updates
6.9 CSL Limited
6.9.1 CSL Limited Corporation Information
6.9.2 CSL Limited Description and Business Overview
6.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 CSL Limited Pneumonia Vaccine Product Portfolio
6.9.5 CSL Limited Recent Developments/Updates
6.10 Emergent Biosolutions
6.10.1 Emergent Biosolutions Corporation Information
6.10.2 Emergent Biosolutions Description and Business Overview
6.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Emergent Biosolutions Pneumonia Vaccine Product Portfolio
6.10.5 Emergent Biosolutions Recent Developments/Updates
6.11 Walvax Biotechnology
6.11.1 Walvax Biotechnology Corporation Information
6.11.2 Walvax Biotechnology Pneumonia Vaccine Description and Business Overview
6.11.3 Walvax Biotechnology Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Walvax Biotechnology Pneumonia Vaccine Product Portfolio
6.11.5 Walvax Biotechnology Recent Developments/Updates
6.12 Royal (Wuxi) Bio-Pharmaceutical
6.12.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information
6.12.2 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Description and Business Overview
6.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Portfolio
6.12.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
6.13 Zhifei Biologic
6.13.1 Zhifei Biologic Corporation Information
6.13.2 Zhifei Biologic Pneumonia Vaccine Description and Business Overview
6.13.3 Zhifei Biologic Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Zhifei Biologic Pneumonia Vaccine Product Portfolio
6.13.5 Zhifei Biologic Recent Developments/Updates

7 Pneumonia Vaccine Manufacturing Cost Analysis
7.1 Pneumonia Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pneumonia Vaccine
7.4 Pneumonia Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pneumonia Vaccine Distributors List
8.3 Pneumonia Vaccine Customers

9 Pneumonia Vaccine Market Dynamics
9.1 Pneumonia Vaccine Industry Trends
9.2 Pneumonia Vaccine Growth Drivers
9.3 Pneumonia Vaccine Market Challenges
9.4 Pneumonia Vaccine Market Restraints

10 Global Market Forecast
10.1 Pneumonia Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pneumonia Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pneumonia Vaccine by Type (2022-2027)
10.2 Pneumonia Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pneumonia Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pneumonia Vaccine by Application (2022-2027)
10.3 Pneumonia Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pneumonia Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pneumonia Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Pneumonia Vaccine Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Pneumonia Vaccine Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global Pneumonia Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Pneumonia Vaccine Covered in This Study
Table 5. Global Pneumonia Vaccine Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Pneumonia Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Pneumonia Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Pneumonia Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Pneumonia Vaccine Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Pneumonia Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Pneumonia Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pneumonia Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pneumonia Vaccine Sales by Region (2016-2021) & (K Doses)
Table 16. Global Pneumonia Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Pneumonia Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Pneumonia Vaccine Sales by Country (2016-2021) & (K Doses)
Table 19. North America Pneumonia Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Pneumonia Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Pneumonia Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Pneumonia Vaccine Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Pneumonia Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Pneumonia Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Pneumonia Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Pneumonia Vaccine Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Pneumonia Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Pneumonia Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Pneumonia Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Pneumonia Vaccine Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Pneumonia Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Pneumonia Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Pneumonia Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Pneumonia Vaccine Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Pneumonia Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Pneumonia Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Pneumonia Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Pneumonia Vaccine Sales (K Doses) by Type (2016-2021)
Table 39. Global Pneumonia Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Pneumonia Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Pneumonia Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Pneumonia Vaccine Price (USD/Dose) by Type (2016-2021)
Table 43. Global Pneumonia Vaccine Sales (K Doses) by Application (2016-2021)
Table 44. Global Pneumonia Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Pneumonia Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Pneumonia Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Pneumonia Vaccine Price (USD/Dose) by Application (2016-2021)
Table 48. Pfizer Inc. Corporation Information
Table 49. Pfizer Inc. Description and Business Overview
Table 50. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. Pfizer Inc. Pneumonia Vaccine Product
Table 52. Pfizer Inc. Recent Developments/Updates
Table 53. Glaxosmithkline Plc. Corporation Information
Table 54. Glaxosmithkline Plc. Description and Business Overview
Table 55. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Glaxosmithkline Plc. Pneumonia Vaccine Product
Table 57. Glaxosmithkline Plc. Recent Developments/Updates
Table 58. Merck & Co., Inc. Corporation Information
Table 59. Merck & Co., Inc. Description and Business Overview
Table 60. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Merck & Co., Inc. Pneumonia Vaccine Product
Table 62. Merck & Co., Inc. Recent Developments/Updates
Table 63. Sanofi Pasteur Corporation Information
Table 64. Sanofi Pasteur Description and Business Overview
Table 65. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. Sanofi Pasteur Pneumonia Vaccine Product
Table 67. Sanofi Pasteur Recent Developments/Updates
Table 68. Serum Institute of India Pvt. Ltd. Corporation Information
Table 69. Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 70. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product
Table 72. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 73. Johnson & Johnson Corporation Information
Table 74. Johnson & Johnson Description and Business Overview
Table 75. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Johnson & Johnson Pneumonia Vaccine Product
Table 77. Johnson & Johnson Recent Developments/Updates
Table 78. Astellas Pharma Inc. Corporation Information
Table 79. Astellas Pharma Inc. Description and Business Overview
Table 80. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. Astellas Pharma Inc. Pneumonia Vaccine Product
Table 82. Astellas Pharma Inc. Recent Developments/Updates
Table 83. Astrazeneca Plc. Corporation Information
Table 84. Astrazeneca Plc. Description and Business Overview
Table 85. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. Astrazeneca Plc. Pneumonia Vaccine Product
Table 87. Astrazeneca Plc. Recent Developments/Updates
Table 88. CSL Limited Corporation Information
Table 89. CSL Limited Description and Business Overview
Table 90. CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. CSL Limited Pneumonia Vaccine Product
Table 92. CSL Limited Recent Developments/Updates
Table 93. Emergent Biosolutions Corporation Information
Table 94. Emergent Biosolutions Description and Business Overview
Table 95. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 96. Emergent Biosolutions Pneumonia Vaccine Product
Table 97. Emergent Biosolutions Recent Developments/Updates
Table 98. Walvax Biotechnology Corporation Information
Table 99. Walvax Biotechnology Description and Business Overview
Table 100. Walvax Biotechnology Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 101. Walvax Biotechnology Pneumonia Vaccine Product
Table 102. Walvax Biotechnology Recent Developments/Updates
Table 103. Royal (Wuxi) Bio-Pharmaceutical Corporation Information
Table 104. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
Table 105. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product
Table 107. Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
Table 108. Zhifei Biologic Corporation Information
Table 109. Zhifei Biologic Description and Business Overview
Table 110. Zhifei Biologic Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 111. Zhifei Biologic Pneumonia Vaccine Product
Table 112. Zhifei Biologic Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Pneumonia Vaccine Distributors List
Table 116. Pneumonia Vaccine Customers List
Table 117. Pneumonia Vaccine Market Trends
Table 118. Pneumonia Vaccine Growth Drivers
Table 119. Pneumonia Vaccine Market Challenges
Table 120. Pneumonia Vaccine Market Restraints
Table 121. Global Pneumonia Vaccine Sales Forecast by Type (2022-2027) & (K Doses)
Table 122. Global Pneumonia Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 123. Global Pneumonia Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 124. Global Pneumonia Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 125. Global Pneumonia Vaccine Sales Forecast by Application (2022-2027) & (K Doses)
Table 126. Global Pneumonia Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 127. Global Pneumonia Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 128. Global Pneumonia Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 129. Global Pneumonia Vaccine Sales Forecast by Region (2022-2027) & (K Doses)
Table 130. Global Pneumonia Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 131. Global Pneumonia Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 132. Global Pneumonia Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pneumonia Vaccine
Figure 2. Global Pneumonia Vaccine Market Share by Type in 2020 & 2027
Figure 3. Pneumococcal Conjugate Vaccine (PCV13) Product Picture
Figure 4. Pneumococcal Polysaccharide Vaccine (PPSV23) Product Picture
Figure 5. Other Product Picture
Figure 6. Global Pneumonia Vaccine Market Share by Application in 2020 & 2027
Figure 7. Pneumonia
Figure 8. Meningitis
Figure 9. Sepsis
Figure 10. Global Pneumonia Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pneumonia Vaccine Market Size 2016-2027 (US$ Million)
Figure 12. Global Pneumonia Vaccine Sales 2016-2027 (K Doses)
Figure 13. Global Pneumonia Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Pneumonia Vaccine Sales Share by Manufacturers in 2020
Figure 15. Global Pneumonia Vaccine Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Pneumonia Vaccine Players: Market Share by Revenue in 2020
Figure 17. Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Pneumonia Vaccine Sales Market Share by Region (2016-2021)
Figure 19. Global Pneumonia Vaccine Sales Market Share by Region in 2020
Figure 20. Global Pneumonia Vaccine Revenue Market Share by Region (2016-2021)
Figure 21. Global Pneumonia Vaccine Revenue Market Share by Region in 2020
Figure 22. U.S. Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Pneumonia Vaccine by Type (2016-2021)
Figure 47. Sales Market Share of Pneumonia Vaccine by Application (2016-2021)
Figure 48. Sales Market Share of Pneumonia Vaccine by Application in 2020
Figure 49. Revenue Share of Pneumonia Vaccine by Application (2016-2021)
Figure 50. Revenue Share of Pneumonia Vaccine by Application in 2020
Figure 51. Manufacturing Cost Structure of Pneumonia Vaccine
Figure 52. Manufacturing Process Analysis of Pneumonia Vaccine
Figure 53. Pneumonia Vaccine Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed